Adult patients w/ type 2 DM to improve glycaemic control in conjunction w/ diet & exercise as monotherapy or as add-on to metformin, sulphonylureas, thiazolidinediones, insulin (w/ or w/o metformin &/or sulphonylurea), or metformin + sulfonylureas or metformin + empagliflozin.
Do not use in patients w/ type 1 diabetes or for the treatment of diabetic ketoacidosis. Discontinue if pancreatitis & bullous pemphigoid are suspected. Hypoglycemia; concomitant use w/ sulphonylurea. Pregnancy & lactation. Childn <18 yr.